SCHEMBL3560280

SCHEMBL3560280

O=C(O)CCc1ccccc1OCCOc1ccc(NS(=O)(=O)c2cccc3ccccc23)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 1/20 0.55
FABP1 P07148 2/20 0.52
TSHR P16473 1/20 0.52
FFAR1 O14842 1/20 0.47
AKR1B1 P15121 1/20 0.47
CASP1 P29466 1/20 0.46
MCL1 Q07820 3/20 0.46
BCL2L1 Q07817 1/20 0.46
POLB P06746 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
ALDH1A1 P00352 1/20 0.45
HTT P42858 1/20 0.45
PFKFB3 Q16875 1/20 0.45
HDAC1 Q13547 1/20 0.44
FABP4 P15090 1/20 0.44
SLC16A3 O15427 2/20 0.44
RORA P35398 1/20 0.43
RORC P51449 1/20 0.43
NR1H2 P55055 1/20 0.43
NR1H4 Q96RI1 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3557644 0.87 EDNRA (0.50) FABP1TSHRMCL1HDAC1FABP4
SCHEMBL3557946 0.86 FABP1 (0.47) FABP1POLBTDP1ALDH1A1
SCHEMBL3554982 0.84 TDP1 (0.59) PGRFABP1POLBTDP1ALDH1A1
SCHEMBL3558852 0.83 SLC22A12 (0.48) FABP1POLBTDP1ALDH1A1
SCHEMBL4778244 0.83 MEN1 (0.53) FABP1TSHRPOLBTDP1ALDH1A1
SCHEMBL3556010 0.83 FFAR4 (0.47) FABP1FFAR1POLBTDP1FABP4
SCHEMBL3556046 0.83 PGR (0.54) PGRFABP1POLBTDP1ALDH1A1
SCHEMBL3554421 0.83 AR (0.59) FABP1POLBTDP1HTT
SCHEMBL3554255 0.82 TDP1 (0.47) FABP1FFAR1POLBTDP1
SCHEMBL3560539 0.82 POLB (0.45) FABP1FFAR1POLBTDP1FABP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7816397-B2 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes MERCK PATENT GMBH (DE) 2010-10-19 US claimed
US-20080045483-A1 Phenylcarboxylic Acid Derivatives and Use Thereof for the Treatment of Diabetes MERCK PATENT GMBH (DE) 2008-02-21 US claimed
US-7816397-B2 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes MERCK PATENT GMBH (DE) 2010-10-19 US disclosed
US-20080045483-A1 Phenylcarboxylic Acid Derivatives and Use Thereof for the Treatment of Diabetes MERCK PATENT GMBH (DE) 2008-02-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080045483-A1 Phenylcarboxylic Acid Derivatives and Use Thereof for the Treatment of Diabetes SLC5A1, ALDH7A1, ASS1 PGR 1338/4885FABP1 521/4885TSHR 3483/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.